Zimmermann J, van Haren S, Diray-Arce J, Adriawan I, Worzner K, Krog R
NPJ Vaccines. 2023; 8(1):189.
PMID: 38135685
PMC: 10746746.
DOI: 10.1038/s41541-023-00781-0.
Cohen K, De Rosa S, Fulp W, deCamp A, Fiore-Gartland A, Mahoney C
Sci Transl Med. 2023; 15(697):eadf3309.
PMID: 37224227
PMC: 11036875.
DOI: 10.1126/scitranslmed.adf3309.
Brander C, Hartigan-OConnor D
Curr Opin HIV AIDS. 2022; 17(6):333-337.
PMID: 36165078
PMC: 9530002.
DOI: 10.1097/COH.0000000000000765.
Bigay J, Le Grand R, Martinon F, Maisonnasse P
Front Microbiol. 2022; 13:932408.
PMID: 36033843
PMC: 9399815.
DOI: 10.3389/fmicb.2022.932408.
Klessing S, Temchura V, Tannig P, Peter A, Christensen D, Lang R
Vaccines (Basel). 2020; 8(4).
PMID: 33066267
PMC: 7711721.
DOI: 10.3390/vaccines8040604.
Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids.
Wang W, Zheng Q, Pan D, Yu H, Fu W, Liu J
Nat Microbiol. 2020; 5(12):1542-1552.
PMID: 32895526
PMC: 7677223.
DOI: 10.1038/s41564-020-0785-y.
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine.
Curlin M, Shao J, Diaz G, Edlefsen P, Novak R, Mayer K
Vaccine. 2020; 38(36):5814-5821.
PMID: 32680773
PMC: 8357155.
DOI: 10.1016/j.vaccine.2020.06.043.
Strong T1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy.
Chamcha V, Reddy P, Kannanganat S, Wilkins C, Gangadhara S, Velu V
Sci Transl Med. 2019; 11(519).
PMID: 31748228
PMC: 7227795.
DOI: 10.1126/scitranslmed.aav1800.
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.
Pauthner M, Nkolola J, Havenar-Daughton C, Murrell B, Reiss S, Bastidas R
Immunity. 2018; 50(1):241-252.e6.
PMID: 30552025
PMC: 6335502.
DOI: 10.1016/j.immuni.2018.11.011.
Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.
Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O
J Clin Invest. 2018; 129(2):875-886.
PMID: 30511963
PMC: 6355215.
DOI: 10.1172/JCI124473.
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
Miller C, Emanuelli M, Fink E, Musselman E, Mackie R, Troyer R
NPJ Vaccines. 2018; 3:16.
PMID: 29736270
PMC: 5928050.
DOI: 10.1038/s41541-018-0051-y.
Applications of the FIV Model to Study HIV Pathogenesis.
Miller C, Abdo Z, Ericsson A, Elder J, VandeWoude S
Viruses. 2018; 10(4).
PMID: 29677122
PMC: 5923500.
DOI: 10.3390/v10040206.
Novel Concepts for HIV Vaccine Vector Design.
Alayo Q, Provine N, Penaloza-MacMaster P
mSphere. 2017; 2(6).
PMID: 29242831
PMC: 5717324.
DOI: 10.1128/mSphere.00415-17.
Conserved HIV Epitopes for an Effective HIV Vaccine.
Sahay B, Nguyen C, Yamamoto J
J Clin Cell Immunol. 2017; 8(4).
PMID: 29226015
PMC: 5719888.
DOI: 10.4172/2155-9899.1000518.
The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?.
Hosie M, Techakriengkrai N, Beczkowski P, Harris M, Logan N, Willett B
Vet Sci. 2017; 4(1).
PMID: 29056666
PMC: 5606627.
DOI: 10.3390/vetsci4010007.
Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4 and CD8 T-Cell Responses.
Sauermann U, Radaelli A, Stolte-Leeb N, Raue K, Bissa M, Zanotto C
J Virol. 2017; 91(23).
PMID: 28904195
PMC: 5686736.
DOI: 10.1128/JVI.01120-17.
HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.
Hu H, Liu F, Kim J, Ratto-Kim S
Expert Rev Vaccines. 2016; 15(6):709-17.
PMID: 26814372
PMC: 4955395.
DOI: 10.1586/14760584.2016.1147354.
The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.
Ndhlovu Z, Stampouloglou E, Cesa K, Mavrothalassitis O, Alvino D, Li J
J Virol. 2015; 89(21):10735-47.
PMID: 26269189
PMC: 4621138.
DOI: 10.1128/JVI.01527-15.
Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton S, Kilgore K, Smith S, Reddy S, Hunter E, Robinson H
Proc Natl Acad Sci U S A. 2015; 112(34):10780-5.
PMID: 26261312
PMC: 4553804.
DOI: 10.1073/pnas.1509731112.
Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.
Tsegaye T, Butler K, Luo W, Radzio J, Srinivasan P, Sharma S
J Acquir Immune Defic Syndr. 2015; 69(4):385-94.
PMID: 25886925
PMC: 4485592.
DOI: 10.1097/QAI.0000000000000642.